Ep­i­darex, Sofinno­va dou­ble down on a par­al­lel take on 3rd-gen CAR-T — aim­ing straight at ovar­i­an can­cer

When John Ma­her treat­ed the first head and neck can­cer pa­tient at Guy’s Hos­pi­tal in Lon­don with his pan-ErbB CAR-T back …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.